Measuring HIV Neutralization in a Luciferase Reporter Gene Assay (original) (raw)
References
Wyatt, R., Sodroski, J. (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884–1888. ArticleCASPubMed Google Scholar
Lasky, L. A., Nakamura, G., Smith, D. H., et al. (1987) Delineation of a region of the human immunodeficiency virus gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50, 975–985. ArticleCASPubMed Google Scholar
Berger, E. A. (1997) HIV entry and tropism: the chemokine receptor connection. AIDS 11(suppl. A), S3–S16. PubMed Google Scholar
Berger, E. A., Doms, R. W., Fenyö, E.-M., et al. (1998) A new classification for HIV-1. Nature 391, 240. ArticleCASPubMed Google Scholar
Weissenhorn, W., Dessen, A., Harrison, S. C., et al. (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426–430. ArticleCASPubMed Google Scholar
Chan, D. C., Fass, D., Berger, J. M., et al. (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263–273. ArticleCASPubMed Google Scholar
Salzwedel, K., Smith, E. D., Dey, B., et al. (2000) Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120. J. Virol. 74, 326–333. ArticleCASPubMed Google Scholar
McDougal, J. S., Kennedy, M. S., Orloff, S. L., et al. (1996) Mechanism of human immunodeficiency virus type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody. J. Virol. 70, 5236–5245. CASPubMed Google Scholar
Sullivan, N., Sun, Y., Sattentau, Q., et al. (1998) CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72, 4694–4703. CASPubMed Google Scholar
Wei, X., Decker, J. M., Wang, S., et al. (2003) Antibody neutralization and escape. Nature 422, 307–312. ArticleCASPubMed Google Scholar
Platt, E. J., Wehrly, K., Kuhmann, S. E., et al. (1998) Effects of CCR5 and CD4 cell surface concentrations on infection by macrophage tropic isolates of human immunodeficiency virus type 1. J. Virol. 72, 2855–2864. CASPubMed Google Scholar
Wei, X., Decker, J. M., Liu, H., et al. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 46, 1896–1905. ArticleCASPubMed Google Scholar
Leitner, T., Korber, B., Daniels, M., et al. (2005) HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005. in (T. Leitner, B. Foley, B. Hahn, P. Marx, F. McCutchan, J. W. Mellors, S. Wolinski, and B. Korber eds.), HIV Sequence Compendium 2005, pp. 41–48. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N. Mex. (http://hiv.lanl.gov). Google Scholar
Kwong, P. D., Doyle, M. L., Casper, D. J., et al. (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420, 678–682. ArticleCASPubMed Google Scholar
Richman, D. D., Wrin, T., Little, S. J. et al. (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. (USA) 100, 4144–4149. ArticleCAS Google Scholar
Haynes, B. F, Montefiori, D. C. (2006) Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev. Vaccines 5, 347–363. ArticleCASPubMed Google Scholar
Mascola, J. R., D’Souza, P., Gilbert, P., et al. (2005) Recommendations for the design and use of standard virus panels to assess the neutralizing antibody response elicited by candidate human immunodeficiency virus type 1 vaccines. J. Virol. 79, 10103–10107. ArticleCASPubMed Google Scholar
Li, M., Gao, F., Mascola, J. R., et al. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108–10125. ArticleCASPubMed Google Scholar
Li, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., et al. (2006) Genetic and neutralization properties subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa.. J. Virol., in press. Google Scholar
Brown, B. K., Darden, J. M., Tovanabutra, S., et al. (2005) Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 (HIV-1) isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. J. Virol. 79, 6089–6101. ArticleCASPubMed Google Scholar
Esparza, J. and the Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise. (2005) The Global HIV/AIDS Vaccine Enterprise: Scientific strategic plan. PLoS Medicine 2(2), e25. Google Scholar
Johnson, V. A., Byington, R. E. (1990) Infectivity assay (virus yield assay), in (Aldovani, A., and Walker, B. D., eds.), Techniques in HIV Research, pp71–76. Stockton Press, New York, N.Y. Google Scholar
Montefiori, D. C., Cornell, R. J., Zhou, J. Y., et al. (1994) Complement control proteins, CD46, CD55 and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205, 82–92. ArticleCASPubMed Google Scholar
Louder, M. K., Sambor, A., Chertova, E., et al. (2005) HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity. Virology339, 226–238. ArticleCASPubMed Google Scholar